Accessibility statement

Rebekah Howell
Research Fellow (Trial Coordinator)



Rebekah joined the York Trials Unit as a Research Fellow (Trial Coordinator) in February 2024. Before joining the unit, Rebekah worked as a Trial Manager at the Clinical Trials Unit at the University of Leeds, and as a Research Assistant at the University of Nottingham and the University of Manchester.  

Rebekah has an interest and expertise in clinical trial and project management, and working with the NHS to deliver interventions through to implementation into usual care. 

Rebekah currently works on the YorQuit Trial, which tests different methods to increase smoking cessation among patients most at risk of lung cancer. 


  • BSc (Hons) Psychology - Manchester Metropolitan University
  • MSc Mental Health Research - University of Nottingham
  • Certificate in Person-Centred and Experiential Psychotherapy, Sherwood Psychotherapy Training Institute

University roles

Rebekah is a member of the Athena Swan Working Group (Career Progression and Pay Gap Group), the Green Impact initiative, and the Rainbow Alliance.



Rebekah’s research experience and interests are varied, with an overarching focus on psychiatry, and medicine. 

Rebekah has worked on a myriad of trials including those studying dementia, autism spectrum disorders, major trauma and injury, smoking cessation, familial hypercholesterolaemia, atrial fibrillation, and late-phase cancer drug interventions. 


  • YorQuit

Research group(s)


Selected publications

  • Begh, R., Coleman, T., Yardley, L. et al. Examining the effectiveness of general practitioner and nurse promotion of electronic cigarettes versus standard care for smoking reduction and abstinence in hardcore smokers with smoking-related chronic disease: protocol for a randomised controlled trial. Trials 20, 659 (2019).
  • Coleman TClark MWelch CWhitemore RLeonardi-Bee JCooper S, et al. Effectiveness of offering tailored text message, self-help smoking cessation support to pregnant women who want information on stopping smoking: MiQuit3 randomised controlled trial and meta-analysisAddiction202211710791094
  • Leadbitter, K., Smallman, R., James, K. et al. REACH-ASD: a UK randomised controlled trial of a new post-diagnostic psycho-education and acceptance and commitment therapy programme against treatment-as-usual for improving the mental health and adjustment of caregivers of children recently diagnosed with autism spectrum disorder. Trials 23, 585 (2022).

Full publications list

Rebekah Howell

Contact details

Rebekah Howell
Research Fellow (Trial Coordinator)

Tel: 01904 32(3909)